menu search

Fmls:23 speaker spotlight – optimised cybersecurity planning and budget formulation

A growing complexity of threats has in turn necessitated a stronger emphasis on cybersecurity. This trend has not been relegated to a single industry ...

November 1, 2023, 11:11 am

Pharmadrug to acquire securedose synthetics in all-stock deal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) announced that it will acquire all of the issued and outstanding shares of Securedose Synthetics Inc, a privat...

October 27, 2023, 9:07 am

Bristol myers' (bmy) opdivo sc meets kidney cancer study goals

Bristol Myers' (BMY) subcutaneous formulation of Opdivo, developed using Halozyme's Enhanze technology,...

October 20, 2023, 6:46 am

Dimethyl sulfoxide market size worth usd 258.3 million by 2031, with a cagr 5.5% | report by transparency market research inc.

Expanding use of dimethyl sulfoxide (DMSO) in drug delivery and formulation, driven by its penetration-...

October 19, 2023, 12:00 am

Milk thistle market anticipates substantial growth with a projected value of us$ 316.35 million by 2033, showing an impressive 8.3% cagr from 2023 to 2033 | future market insights, inc.

Milk Thistle holds a significant market share globally and is gaining grounds among individuals due to its various ...

October 16, 2023, 3:00 pm

Comera life sciences presents sqore™ platform technology data at podd: partnerships in drug delivery conference

WOBURN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generat...

October 16, 2023, 12:00 pm

Cardiol therapeutics says study results show positive effects of subcutaneously administered cannabidiol

Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidiol, the active pharmaceutical ingredient in the...

October 10, 2023, 8:15 am

Outlook therapeutics® requests type a meeting with fda

ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approv...

September 29, 2023, 12:05 pm

Avalyn to provide keynote presentation at the formulation & delivery u.s. 2023 conference

SEATTLE, Sept. 29, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted inhalat...

September 29, 2023, 10:30 am

Scpharmaceuticals: furoscix, charting a bright future with fda's nod for ckd

Positive FDA feedback for Furoscix's label expansion into chronic kidney disease signals the potential for significant market growth. Introduction of ...

September 27, 2023, 12:40 am

Appili therapeutics' shares soar on fda approval for llikmez oral antibiotic

Appili Therapeutics Inc (TSX-V:APLI) shares rallied after it announced the US Food and Drug Administration (FDA) approved its application for a liquid...

September 25, 2023, 11:52 am

Outlook therapeutics® to present at the 2023 cantor fitzgerald global healthcare conference

Live video webcast panel presentation on Tuesday, September 26th at 1:35 PM ET ISELIN, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics,...

September 21, 2023, 12:05 pm

Voyageur pharmaceuticals achieves milestone in the development of hdxba barium contrast media

Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) told investors it has completed the formulation and ...

September 14, 2023, 9:43 am

Dupont's (dd) delrin introduces breakthrough new resin

The new resin by DuPont's (DD) unit Delrin is based on formulations that have set the bar for high-perf...

September 14, 2023, 8:16 am

Opko health (opk) ties up for oral peptide tablet formulations

OPKO Health's (OPK) latest Research Collaboration Agreement is likely to enable it to expand its pipeline to develop orally administered tablet presen...

September 13, 2023, 3:02 pm

Viatris (vtrs) gets tentative approval for hiv regimen for kids

Viatris (VTRS) obtains tentative approval from the FDA for a pediatric formulation of abacavir/dolutegr...

September 5, 2023, 12:02 pm

Optimi health announces second tranche of cad $1,000,000 secured for debt financing

Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and ...

September 5, 2023, 12:01 pm

Congestive heart failure drugs market 2023-2030| poised for strong growth in future

The “Congestive Heart Failure Drugs Market” Report for the period 2023-2030 facilitates the formulation...

September 3, 2023, 7:14 pm


Search within

Pages Search Results: